Jean-Claude Boulain

Title: Innovations of Jean-Claude Boulain

Introduction

Jean-Claude Boulain is a notable inventor based in Palaiseau, France. He has made significant contributions to the field of molecular complexes, particularly in the area of targeting antigens for vaccination purposes. With a total of 6 patents to his name, Boulain's work has the potential to impact vaccine development and immunotherapy.

Latest Patents

One of his latest patents is titled "Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination." This invention relates to a molecular complex designed to target antigens towards cells. It includes at least one antigen associated with two ligands of surface molecules of cells. The complex features a first ligand of a sulphated sugar from the glycosaminoglycan family and a second ligand of a specific surface molecule of cells. The first ligand is covalently bonded with the antigen and/or the second ligand. This innovative approach aims to enhance the efficacy of vaccinations.

Career Highlights

Throughout his career, Jean-Claude Boulain has worked with prominent organizations, including the Commissariat à l'Énergie Atomique and the Commissariat à l'Énergie Atomique et aux Énergies Alternatives. His experience in these institutions has allowed him to develop and refine his inventions in the field of molecular biology and immunology.

Collaborations

Boulain has collaborated with notable colleagues such as Frederic Ducancel and Andre Menez. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jean-Claude Boulain's innovative work in molecular complexes for targeting antigens showcases his significant contributions to the field of vaccination and immunotherapy. His patents reflect a commitment to advancing medical science and improving public health.